Literature DB >> 1738208

A chimera of EBNA1 and the estrogen receptor activates transcription but not replication.

T Middleton1, B Sugden.   

Abstract

DNA replication from the plasmid origin of replication of Epstein-Barr virus requires one viral protein, EBNA1. This protein also acts as a transcriptional activator. Mutational analyses of EBNA1 have led to the conclusion that it supports transcription and DNA replication similarly. Such analyses have not probed the DNA-binding domain of EBNA1. To test whether domains of EBNA1 specifically required for either transcription or replication lie within its DNA-binding domain, we constructed a functional transcriptional activator by placing the EBNA1 DNA-binding domain in the context of the activation domains of the estrogen receptor. This hybrid protein did not support DNA replication, which indicates that the DNA-binding domain does not contain a replication-specific domain that can function along with heterologous transcriptional activating domains.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1738208      PMCID: PMC240942     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection.

Authors:  B Sugden; N Warren
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

2.  The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication.

Authors:  T A Gahn; C L Schildkraut
Journal:  Cell       Date:  1989-08-11       Impact factor: 41.582

3.  Replication of latent Epstein-Barr virus genomes in Raji cells.

Authors:  A Adams
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

4.  A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components.

Authors:  D Reisman; J Yates; B Sugden
Journal:  Mol Cell Biol       Date:  1985-08       Impact factor: 4.272

5.  trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1.

Authors:  D Reisman; B Sugden
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

6.  Mutational analysis of Epstein-Barr virus nuclear antigen 1 (EBNA 1).

Authors:  M Polvino-Bodnar; J Kiso; P A Schaffer
Journal:  Nucleic Acids Res       Date:  1988-04-25       Impact factor: 16.971

7.  Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells.

Authors:  J L Yates; N Warren; B Sugden
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

8.  Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells.

Authors:  S Lupton; A J Levine
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

9.  Functional limits of oriP, the Epstein-Barr virus plasmid origin of replication.

Authors:  T Chittenden; S Lupton; A J Levine
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

10.  Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region.

Authors:  D R Rawlins; G Milman; S D Hayward; G S Hayward
Journal:  Cell       Date:  1985-10       Impact factor: 41.582

View more
  6 in total

1.  Rep*: a viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus.

Authors:  A L Kirchmaier; B Sugden
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

2.  Dominant-negative inhibitors of EBNA-1 of Epstein-Barr virus.

Authors:  A L Kirchmaier; B Sugden
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  Retention of plasmid DNA in mammalian cells is enhanced by binding of the Epstein-Barr virus replication protein EBNA1.

Authors:  T Middleton; B Sugden
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

4.  Plasmid maintenance of derivatives of oriP of Epstein-Barr virus.

Authors:  A L Kirchmaier; B Sugden
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

5.  Cell fusion induced by the murine leukemia virus envelope glycoprotein.

Authors:  J S Jones; R Risser
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

6.  Methylation patterns of papillomavirus DNA, its influence on E2 function, and implications in viral infection.

Authors:  Kitai Kim; Peggy A Garner-Hamrick; Chris Fisher; Denis Lee; Paul F Lambert
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.